Youyou Zhou

507 total citations
20 papers, 383 citations indexed

About

Youyou Zhou is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Youyou Zhou has authored 20 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Youyou Zhou's work include Neonatal Health and Biochemistry (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Methemoglobinemia and Tumor Lysis Syndrome (3 papers). Youyou Zhou is often cited by papers focused on Neonatal Health and Biochemistry (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Methemoglobinemia and Tumor Lysis Syndrome (3 papers). Youyou Zhou collaborates with scholars based in China, Singapore and United States. Youyou Zhou's co-authors include Juan Su, Cong Peng, Xiang Chen, Zunnan Huang, Samuel S. Chong, Jianglin Zhang, Xiang Chen, Lei Zhou, Xu Zhang and Zhongling Luo and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Youyou Zhou

18 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Youyou Zhou China	12	203	80	56	49	46	20	383
Lijun Dai China	13	153 0.8×	54 0.7×	41 0.7×	95 1.9×	13 0.3×	30	470
Zafer Çetin Türkiye	12	185 0.9×	37 0.5×	106 1.9×	52 1.1×	63 1.4×	53	496
Henning Hvid Denmark	14	191 0.9×	40 0.5×	56 1.0×	79 1.6×	8 0.2×	34	482
Qin Huang China	11	108 0.5×	29 0.4×	22 0.4×	33 0.7×	11 0.2×	19	368
Hassen Kamoun Tunisia	15	266 1.3×	55 0.7×	145 2.6×	31 0.6×	11 0.2×	60	482
Qi Han China	13	219 1.1×	113 1.4×	8 0.1×	41 0.8×	15 0.3×	36	466
Wenqi Shan China	14	248 1.2×	80 1.0×	20 0.4×	54 1.1×	5 0.1×	23	458
Nuo Cheng China	10	178 0.9×	45 0.6×	14 0.3×	46 0.9×	9 0.2×	31	325
Xing Wan China	11	239 1.2×	104 1.3×	14 0.3×	25 0.5×	4 0.1×	43	410
Lingling Jiang China	13	144 0.7×	49 0.6×	12 0.2×	43 0.9×	13 0.3×	42	449

Countries citing papers authored by Youyou Zhou

Since Specialization

Citations

This map shows the geographic impact of Youyou Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youyou Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youyou Zhou more than expected).

Fields of papers citing papers by Youyou Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youyou Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youyou Zhou. The network helps show where Youyou Zhou may publish in the future.

Co-authorship network of co-authors of Youyou Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Youyou Zhou. A scholar is included among the top collaborators of Youyou Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youyou Zhou. Youyou Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xia, Yaoyao, Youyou Zhou, Jianglin Zhang, et al.. (2025). Glycerophospholipid metabolism licenses IgE-mediated mast cell degranulation. Cell Reports. 44(6). 115742–115742.

Li, Chang, et al.. (2025). Nivolumab-induced subacute cutaneous lupus erythematosus in a patient with sigmoid colon cancer: a case report and review of the literature. Frontiers in Oncology. 15. 1674823–1674823.

Liu, Panpan, Youyou Zhou, Chao Chen, et al.. (2023). Lysophosphatidylcholine facilitates the pathogenesis of psoriasis through activating keratinocytes and T cells differentiation via glycolysis. Journal of the European Academy of Dermatology and Venereology. 37(7). 1344–1360. 15 indexed citations

Zhou, Youyou, et al.. (2023). Sterigmatocystin induced cytotoxicity and disturbed lipid metabolism. Journal of Agriculture and Food Research. 14. 100673–100673. 2 indexed citations

Wang, Ying, Youyou Zhou, Yingfang Wu, et al.. (2021). Fine particulate matter (PM2.5) promotes IgE-mediated mast cell activation through ROS/Gadd45b/JNK axis. Journal of Dermatological Science. 102(1). 47–57. 28 indexed citations

Deng, Haowen, et al.. (2021). Ensemble learning for the early prediction of neonatal jaundice with genetic features. BMC Medical Informatics and Decision Making. 21(1). 338–338. 17 indexed citations

Zheng, Jing, Youyou Zhou, Juan Liao, et al.. (2020). Long noncoding RNA ZFAS1 silencing alleviates rheumatoid arthritis via blocking miR-296-5p-mediated down-regulation of MMP-15. International Immunopharmacology. 90. 107061–107061. 23 indexed citations

Wang, Yue, Youyou Zhou, Yanfu Wang, Cong Peng, & Mingyang Gao. (2020). Cloning of the XPD gene and its function in malignant melanoma cells. Oncology Letters. 20(2). 1803–1809. 1 indexed citations

Xu, Chao, Dan Song, Askild Lorentz Holck, Youyou Zhou, & Rong Liu. (2020). Identifying Lipid Metabolites Influenced by Oleic Acid Administration Using High-Performance Liquid Chromatography–Mass Spectrometry-Based Lipidomics. ACS Omega. 5(20). 11314–11323. 10 indexed citations

10.

Yang, Lin, et al.. (2019). A novel deletion with two pathogenic variants of UGT1A1 causing Crigler-Najjar syndrome in two unrelated Chinese. Clinical Biochemistry. 71. 67–68. 2 indexed citations

11.

Zhou, Youyou, Zunnan Huang, Juan Su, et al.. (2019). Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment. International Journal of Cancer. 147(1). 139–151. 63 indexed citations

12.

Hu, Xing, Juan Su, Youyou Zhou, et al.. (2017). Repressing CD147 is a novel therapeutic strategy for malignant melanoma. Oncotarget. 8(15). 25806–25813. 37 indexed citations

13.

Zhou, Youyou, Yanfu Wang, Juan Su, et al.. (2017). Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation. Oncotarget. 8(53). 90879–90896. 17 indexed citations

14.

Zhang, Jianglin, Lei Zhou, Zunnan Huang, et al.. (2016). Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity. Oncotarget. 7(48). 79557–79571. 69 indexed citations

15.

Zhou, Youyou, et al.. (2015). Effects of curcumin on the AKT/mTOR signaling pathway in human melanoma cell lines A375 and C8161. Chinese Journal of Dermatology. 48(6). 382–386. 1 indexed citations

16.

Zhou, Youyou, Jian Sun, Qianqian Peng, et al.. (2014). Association of UGT1A1 Variants and Hyperbilirubinemia in Breast-Fed Full-Term Chinese Infants. PLoS ONE. 9(8). e104251–e104251. 23 indexed citations

17.

Zhou, Youyou, Hong Li, Qianqian Peng, et al.. (2014). Quantitative Trait Analysis of Polymorphisms in Two Bilirubin Metabolism Enzymes to Physiologic Bilirubin Levels in Chinese Newborns. The Journal of Pediatrics. 165(6). 1154–1160.e1. 18 indexed citations

18.

Goh, Denise, et al.. (2007). Novel CFTR gene mutation in a patient with CBAVD. Journal of Cystic Fibrosis. 6(6). 423–425. 6 indexed citations

19.

Zhou, Youyou, Kun Tang, Hai‐Yang Law, et al.. (2006). FMR1 CGG Repeat Patterns and Flanking Haplotypes in Three Asian Populations and Their Relationship With Repeat Instability. Annals of Human Genetics. 70(6). 784–796. 19 indexed citations

20.

Zhou, Youyou, et al.. (2006). Simplified Molecular Diagnosis of Fragile X Syndrome by Fluorescent Methylation-Specific PCR and GeneScan Analysis. Clinical Chemistry. 52(8). 1492–1500. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact